Impact of HPV vaccine availability on uptake

Journal for Nurse Practitioners

Volumn 8, Issue 1, 2012, Pages 61-66

  Small, Stephanie L ^a   Patel, Divya A ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

HPV; Human papillomavirus; Uptake; Vaccine

Indexed keywords

EID: 84855443283     PISSN: 15554155     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurpra.2011.06.005     Document Type: Article

References (21)

1. Brewer NT, Fazekas KI Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Prev Med 2007, 45(2-3):107-114.
2. National, state, and local area vaccination coverage among adolescents aged 13-17 years - United States, 2009. Morb Mortal Weekly Rep 2010, 59(32):1018-1023.
3. Jain N, Euler GL, Shefer A, et al. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, national immunization survey-adult 2007. Prev Med 2009, 48(5):426-431.
4. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA 2007, 297(8):813-819.
5. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300.
6. Brisson M, Van de Velde N, Boily MC Economic evaluation of human papillomavirus vaccination in developed countries. Public Health Genomics 2009, 12(5-6):343-351.
7. Kim JJ, Goldie SJ Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. Br Med J 2009, 339(b3884):909.
8. Caskey R, Lindau ST, Alexander GC Knowledge and early adoption of the HPV vaccine among girls and young women: Results of a national survey. J Adolesc Health 2009, 45(5):453-462.
9. Chao C, Velicer C, Slezak J, et al. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol 2010, 171(3):357-367.
10. Conroy K, Rosenthal SL, Zimet GD, et al. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Women Health 2009, 18(10):1679-1686.
11. Dempsey AF, Abraham LM, Dalton V, et al. Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol 2009, 19(8):531-538.
12. Dempsey A, Cohn L, Dalton V, et al. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine 2010, 28(4):989-995.
13. Gerend MA, Weibley E, Bland H Parental response to human papillomavirus vaccine availability: Uptake and intentions. J Adolesc Health 2009, 45(5):528-531.
14. Gottlieb SL, Brewer NT, Sternberg MR, et al. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health 2009, 45(5):430-437.
15. Jain N, Euler GL, Shefer A, et al. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, national immunization survey-adult 2007. Prev Med 2009, 48(5):426-431.
16. Licht AS, Murphy JM, Hyland AJ, et al. Is use of the HPV vaccine among female college students related to HPV knowledge and risk perception?. Sex Transm Infect 2010, 86(1):74-78.
17. Mathur M, Mathur V, Reichling D Participation in the decision to become vaccinated against human papillomavirus by California high school girls and the predictors of vaccine status. J Pediatr Health Care 2010, 24(1):14-24.
18. Reiter P, Cates J, McRee A, et al. Statewide HPV vaccine initiation among adolescent females in North Carolina. Sex Transm Dis 2010, 37(9):549-556.
19. Rosenthal SL, Weiss TW, Zimet GD, et al. Predictors of HPV vaccine uptake among women aged 19-26: Importance of a physician's recommendation. Vaccine 2011, 29(5):890-895.
20. Daley E, Vamos C, Buhi E, et al. Influences on human papillomavirus vaccination status among female college students. J Women Health 2010, 19(10):1885-1891.
21. Planned Parenthood Mission [Internet] Accessed March 30, 2011. http://www.plannedparenthood.org.